Why Shares of TransMedics Stock Plunged This Week
Shares of TransMedics (NASDAQ: TMDX), a leader in heart, lung, and liver transplant technologies, have plummeted 15% in the past week as of 4 p.m. ET Thursday, according to data provided by S&P Global Market Intelligence.
While no specific news led to the company's drop, the movement is probably tied to the stock's increasing volatility following a remarkable doubling in value over the last year.
In the last year, TransMedics' one-year beta -- which measures a stock's relative volatility compared to the market -- rose from 1.6 to 5.1. With a beta above 1 indicating higher volatility, the company's high and rising mark of 5.1 shows that it is truly one of the wilder rides out there on the market.
Source Fool.com
